Free tool
Stocks listed on Nasdaq GS
We cover 48 companies listed on Nasdaq GS. The median market value in the group is $22.18B. Across the group, the median move over the past trading day is −0.18%. 81% of the 47 with a 200-day average trade above it. Price change over the past year runs from −6.8% to +180.4% across the middle 80 percent of the group, with a median of +40.0%.
Other lists in this group
Table
48 of 1,279 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return | Next report |
|---|---|---|---|---|---|
| AMGN | Amgen Inc. | $238.06B | Mega cap | +56.24% | Nov 3, 2026 |
| GILD | Gilead Sciences, Inc. | $184.47B | Large cap | +32.51% | Oct 29, 2026 |
| VRTX | Vertex Pharmaceuticals Incorporated | $138.63B | Large cap | +40.66% | Nov 2, 2026 |
| ISRG | Intuitive Surgical, Inc. | $133.22B | Large cap | −21.38% | Oct 20, 2026 |
| SNY | Sanofi | $108.83B | Large cap | −4.33% | Oct 30, 2026 |
| REGN | Regeneron Pharmaceuticals, Inc. | $83.89B | Large cap | +39.36% | Oct 28, 2026 |
| ARGX | argenx SE | $65.51B | Large cap | +47.90% | Oct 22, 2026 |
| MRNA | Moderna, Inc. | $59.75B | Large cap | +496.25% | Nov 5, 2026 |
| NTRA | Natera, Inc. | $48.53B | Large cap | +107.59% | Nov 5, 2026 |
| MDLN | Medline Inc. | $46.53B | Large cap | −13.07% | Nov 4, 2026 |
| RVMD | Revolution Medicines, Inc. | $46.18B | Large cap | +466.35% | Nov 4, 2026 |
| IDXX | IDEXX Laboratories, Inc. | $43.66B | Large cap | −13.64% | Nov 2, 2026 |
| ONC | BeOne Medicines AG | $42.58B | Large cap | +25.21% | Nov 5, 2026 |
| RPRX | Royalty Pharma plc | $35.71B | Large cap | +74.00% | Nov 4, 2026 |
| ILMN | Illumina, Inc. | $33.95B | Large cap | +125.88% | Oct 29, 2026 |
| DXCM | DexCom, Inc. | $33.65B | Large cap | +16.47% | Oct 29, 2026 |
| GEHC | GE HealthCare Technologies Inc. | $33.35B | Large cap | −1.15% | Oct 28, 2026 |
| BIIB | Biogen Inc. | $32.66B | Large cap | +62.12% | Oct 29, 2026 |
| ALNY | Alnylam Pharmaceuticals, Inc. | $32.12B | Large cap | −47.38% | Oct 29, 2026 |
| BNTX | BioNTech SE | $28.28B | Large cap | +9.27% | Nov 3, 2026 |
| INSM | Insmed Incorporated | $27.16B | Large cap | −7.54% | Oct 29, 2026 |
| ROIV | Roivant Sciences Ltd. | $26.55B | Large cap | +206.51% | Nov 9, 2026 |
| INCY | Incyte Corporation | $25.97B | Large cap | +51.01% | Oct 27, 2026 |
| GH | Guardant Health, Inc. | $22.94B | Large cap | +169.17% | Oct 28, 2026 |
| GMAB | Genmab A/S | $21.42B | Large cap | +36.20% | Nov 5, 2026 |
| VTRS | Viatris Inc. | $19.35B | Large cap | +66.19% | Nov 5, 2026 |
| MEDP | Medpace Holdings, Inc. | $17.28B | Large cap | +30.74% | Oct 19, 2026 |
| JAZZ | Jazz Pharmaceuticals plc | $16.89B | Large cap | +100.35% | Nov 4, 2026 |
| NBIX | Neurocrine Biosciences, Inc. | $15.92B | Large cap | +13.36% | Oct 28, 2026 |
| BBIO | BridgeBio Pharma, Inc. | $15.52B | Large cap | +60.05% | Oct 28, 2026 |
| COO | The Cooper Companies, Inc. | $14.25B | Large cap | −1.93% | Sep 9, 2026 |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +45.68% | Oct 27, 2026 |
| ICLR | ICON Public Limited Company | $13.03B | Large cap | −2.91% | Oct 21, 2026 |
| BMRN | BioMarin Pharmaceutical Inc. | $12.70B | Large cap | +11.85% | Oct 26, 2026 |
| ARWR | Arrowhead Pharmaceuticals, Inc. | $12.52B | Large cap | +308.99% | Nov 24, 2026 |
| MDGL | Madrigal Pharmaceuticals, Inc. | $12.45B | Large cap | +26.78% | Nov 4, 2026 |
| HALO | Halozyme Therapeutics, Inc. | $12.41B | Large cap | +46.30% | Nov 2, 2026 |
| TEM | Tempus AI, Inc. | $12.40B | Large cap | −6.49% | Nov 3, 2026 |
| TECH | Bio-Techne Corporation | $11.35B | Large cap | +29.33% | Nov 9, 2026 |
| BTSG | BrightSpring Health Services, Inc. | $11.32B | Large cap | +156.37% | Oct 30, 2026 |
| ALGN | Align Technology, Inc. | $11.31B | Large cap | +12.09% | Oct 28, 2026 |
| CYTK | Cytokinetics, Incorporated | $11.01B | Large cap | +109.36% | Nov 5, 2026 |
| KRYS | Krystal Biotech, Inc. | $10.65B | Large cap | +143.67% | Nov 2, 2026 |
| IONS | Ionis Pharmaceuticals, Inc. | $10.56B | Large cap | +48.21% | Nov 4, 2026 |
| PRAX | Praxis Precision Medicines, Inc. | $10.54B | Large cap | +704.28% | Nov 9, 2026 |
| ENSG | The Ensign Group, Inc. | $10.43B | Large cap | +5.01% | Nov 3, 2026 |
| HSIC | Henry Schein, Inc. | $10.30B | Large cap | +31.02% | Nov 3, 2026 |
| RGEN | Repligen Corporation | $10.25B | Large cap | +51.67% | Nov 3, 2026 |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.